Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
12 participants
INTERVENTIONAL
2014-10-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smoking Termination / Anxiety Reduction Treatment (ST/ART)
NCT01789125
Coping Skills Treatment for Smoking Cessation
NCT01061528
Adaptation and Initial Evaluation of Transdiagnostic CBT for Anxious and Depressed Smokers
NCT03920137
Smoking Cessation for Depressed Smokers
NCT00494728
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
NCT02697227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Depression and Anxiety Smoking Cessation Treatment
Cognitive-behavioral treatment program that blends smoking cessation, anxiety, and depression management/reduction treatment strategies
Nicotine Patch
Depression and Anxiety Smoking Cessation Treatment
Cognitive-behavioral treatment program that blends smoking cessation, anxiety, and depression management/reduction treatment strategies
Educational-Support Psychotherapy
Educational-based psychotherapy and standard smoking cessation treatment program
Nicotine Patch
Educational-Support Psychotherapy
Educational-based psychotherapy and standard smoking cessation treatment program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine Patch
Depression and Anxiety Smoking Cessation Treatment
Cognitive-behavioral treatment program that blends smoking cessation, anxiety, and depression management/reduction treatment strategies
Educational-Support Psychotherapy
Educational-based psychotherapy and standard smoking cessation treatment program
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of providing informed consent
* Willing to attend all study visits and comply with the protocol
* Daily smoker for at least one year
* Currently smoke an average of at least 6 cigarettes per day
* Report a motivation to quit smoking in the next 6 weeks of at least 5 on a 10-point scale
* Elevated anxiety or depression
Exclusion Criteria
* Current or past psychotic disorders of any type, or comorbid psychiatric conditions that are relative or absolute contraindications to the use of any treatment option in the study protocol
* Currently suicidal or high suicide risk
* Current use of any pharmacotherapy or psychotherapy for smoking cessation not provided by the researchers during the quit attempt
* Concurrent psychotherapy initiated within three months of baseline, or ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety or depression
* Current or intended participation in a concurrent substance abuse treatment
* Current non-nicotine substance dependence
* Insufficient command of English to participate in assessment or treatment
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael J. Zvolensky, Ph.D.
Hugh Roy and Lillie Cranz Cullen Distinguished University Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael J Zvolensky, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anxiety and Health Research Laboratory and Substance Use Treatment Clinic
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1R34DA03474101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.